Initial Data from Ongoing Phase 1 Trial of VIR-3434 for Chronic Hepatitis B Virus Infection Demonstrates Significant and Rapid Reduction in Hepatitis B Surface Antigen

NEXT STORY
Antibody Testing Market Forecast to 2027 – COVID-19 Impact and Global Analysis By Product ; Indication ; End-User, and Geography.
PREV STORY
CloudMD to Acquire Rxi Group of Companies, an Established One-Stop Patient Support Logistics Company and Leading Customer Relationship Management Technology Provider
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cios Flow Mobile C-Arm Market Value Predicted To Reach US$ 4,676.5 Million By 2027 Covering Pre And Post COVID-19 Market Analysis: Acumen Research And Consulting

author_avatar
NASDAQ Market News

Michael Feltes, MD is Appointed to the American Health Council’s Board of Physicians

NEW YORK, June 06, 2018 (GLOBE NEWSWIRE) -- The American Health Council has appointed ...

author_avatar
NASDAQ Market News

Paratek Pharmaceuticals, Inc. Reports First Quarter 2017 Financial Results and Provides Clinical Update

Reported positive Phase 3 study results with omadacycline in community-acquired bacterial pneumonia (CABP)Updated timing ...

author_avatar
NASDAQ Market News